Prion protein: structural features and related toxicity
- PMID: 23615535
- DOI: 10.1093/abbs/gmt035
Prion protein: structural features and related toxicity
Abstract
Transmissible spongiform encephalopathies, or prion diseases, is a group of infectious neurodegenerative disorders. The conformational conversion from cellular form (PrP(C)) to disease-causing isoform (PrP(Sc)) is considered to be the most important and remarkable event in these diseases, while accumulation of PrP(Sc) is thought to be the main reason for cell death, inflammation and spongiform degeneration observed in infected individuals. Although these rare but unique neurodegenerative disorders have attracted much attention, there are still many questions that remain to be answered. Knowledge of the scrapie agent structures and the toxic species may have significance for understanding the causes of the diseases, and could be helpful for rational design of novel therapeutic and diagnostic methods. In this review, we summarized the available experimental evidence concerning the relationship among the structural features, aggregation status of misfolded PrP and related neurotoxicity in the course of prion diseases development. In particular, most data supports the idea that the smaller oligomeric PrP(Sc) aggregates, rather than the mature amyloid fibers, exhibit the highest toxicity to the host.
Keywords: amyloid; oligomer; prion protein; toxicity.
Similar articles
-
Prion protein oligomer and its neurotoxicity.Acta Biochim Biophys Sin (Shanghai). 2013 Jun;45(6):442-51. doi: 10.1093/abbs/gmt037. Epub 2013 Apr 4. Acta Biochim Biophys Sin (Shanghai). 2013. PMID: 23557632 Review.
-
Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion.Methods. 2011 Mar;53(3):306-17. doi: 10.1016/j.ymeth.2010.12.002. Epub 2010 Dec 8. Methods. 2011. PMID: 21145399 Review.
-
The structure of prion: is it enough for interpreting the diverse phenotypes of prion diseases?Acta Biochim Biophys Sin (Shanghai). 2013 Jun;45(6):429-34. doi: 10.1093/abbs/gmt021. Epub 2013 Mar 3. Acta Biochim Biophys Sin (Shanghai). 2013. PMID: 23459557 Review.
-
Conformational conversion of prion protein in prion diseases.Acta Biochim Biophys Sin (Shanghai). 2013 Jun;45(6):465-76. doi: 10.1093/abbs/gmt027. Epub 2013 Apr 11. Acta Biochim Biophys Sin (Shanghai). 2013. PMID: 23580591 Review.
-
Prion encephalopathies of animals and humans.Dev Biol Stand. 1993;80:31-44. Dev Biol Stand. 1993. PMID: 8270114 Review.
Cited by
-
Fibrinogen Mitigates Prion-Mediated Platelet Activation and Neuronal Cell Toxicity.Front Cell Dev Biol. 2022 Mar 21;10:834016. doi: 10.3389/fcell.2022.834016. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35386203 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials